U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2013). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available online: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
Thompson MA, et al. (2012). Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA Panel. JAMA, 308(4): 387-402.
U.S. Centers for Disease Control and Prevention (2014). Preexposure prophylaxis for HIV prevention in the United States - 2014: A clinical practice guideline. U.S. Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed July 27, 2014.
Schneider E, et al. (2008). Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged < 18 months and for HIV infection and AIDS among children aged 18 months to < 13 years-United States, 2008. MMWR, 57(RR-10): 1-12. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5710.pdf.
U.S. Centers for Disease Control and Prevention (1992). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR, 41(RR-17): 1-19.
U.S. Preventive Services Task Force (2013). Screening for HIV: U.S. Preventive Services Task Force recommendation statement. Available online: http://www.uspreventiveservicestaskforce.org/uspstf/uspshivi.htm.
Kuhar DT, et al. (2013). Updated U.S. Public Health Service Guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infection Control and Hospital Epidemiology, 34(9): 875-892.
Centers for Disease Control and Prevention (2005). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Recommendations from the U.S. Department of Health and Human Services. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm.
Grant RM, et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27): 2588-2599.
Baeten JM, et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5): 399-410.
Thigpen MC, et al. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5): 423-434.
Cohen MS, et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, July 18, epub ahead of print (doi:10.1056/NEJMoa1105243).
Porco TC, et al. (2004). Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS, 18(1): 81-88.
Triant VA, et al. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease. Journal of Clinical Endocrinology and Metabolism. Available online: http://jcem.endojournals.org/cgi/rapidpdf/jc.2006-2190v1 (e-pub ahead of print).
Chaturvedi AK, et al. (2007). Elevated risk of lung cancer among people with AIDS. AIDS, 21(2): 207-213.
Aberg JA, et al. (2009). Primary care guidelines for the management of persons infected with HIV: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 49(5): 651-681.
American College of Obstetricians and Gynecologists (2008, reaffirmed 2011). Prenatal and perinatal human immunodeficiency virus testing: Expanded recommendations. ACOG Committee Opinion No. 418. Obstetrics and Gynecology, 112(3): 739-742.
Antiretroviral Therapy Cohort Collaboration (2003). Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: Analysis of prospective studies. Lancet, 362(9385): 679-686.
Del Rio C, Curran JW (2010). Epidemiology and prevention of acquired immunodeficiency syndrome and human inmmunodeficiency virus infection. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1635-1661. Philadelphia: Churchill Livingstone Elsevier.
Eron JJ Jr, Hirsch MS (2008). Antiviral therapy of human immunodeficiency virus infection. In KK Holmes et al., eds., Sexually Transmitted Diseases, 4th ed., pp. 1393-1421. New York: McGraw-Hill.
Jia Z, et al. (2012). Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): A national observational cohort study. Lancet. Published online November 30, 2012 (doi:10.1016/S0140-6736(12)61898-4).
Kitahata MM, et al. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine. Published online April 1, 2009 (doi:10.1056/NEJMoa0807252).
Mocroft A, et al. (2003). Decline in AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377): 22-29.
Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children (2013). Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Rockville, MD: Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. Accessed April 16, 2014.
Rerks-Ngarm S, et al. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine, 361(23): 2209-2220.
Thompson MA, et al. (2010). Antiretroviral treatment of adult HIV infection: 2010 Recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Society, 304(3): 321-333.
U.S. Centers for Disease Control and Prevention (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR, 58(Early Release): 1-207.
World Health Organization (2010). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach, 2010 version. Available online: http://www.who.int/hiv/pub/mtct/antiretroviral2010/en/index.html.
World Health Organization (2010). Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. Available online: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf.
World Health Organization (2010). Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Available online: http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf.
World Health Organization (2010). Guidelines on HIV and infant feeding 2010: Principles and recommendations for infant feeding in the context of HIV and a summary of evidence. Available online: http://whqlibdoc.who.int/publications/2010/9789241599535_eng.pdf.